logo-large
  • Browse Categories

Publications by authors named "C Maharjan"

Claim this Profile
P
Proteolysis Targeting Chimera Loaded Extracellular Vesicles for Developing Triple Negative Breast Cancer Treatment.
Nina Erwin, Umasankar De, Yufeng Xiao, Lei Wang, Chandra K Maharjan

J Extracell Vesicles· December 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Targeting of IKKβ and NR4A1 for AML Therapy.
Chandra K Maharjan, Yi Liu, Yufeng Xiao, Bristy R Podder, Tyler H Montgomery

bioRxiv· September 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-Resident Memory T Cells in Cancer Metastasis Control.
Tyler H Montgomery, Anuj P Master, Zeng Jin, Qiongyu Shi, Qin Lai, Chandra K Maharjan

Cells· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CerS2 is a druggable target in triple-negative breast cancer.
Hissah Alatawi, Haritha H Nair, Lingbao Ai, Iqbal Mahmud, Abhishek Gour, Chandra K Maharjan

bioRxiv· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANGPTL4: A Comprehensive Review of 25 Years of Research.
Pedro Ramos, Qiongyu Shi, Jeremy Kleberg, Chandra K Maharjan, Weizhou Zhang

Cancers (Basel)· July 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: